The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s National Reconstruction Fund Corporation (NRFC) announced on Thursday.

In a groundbreaking development, researchers at MIT have unveiled wireless brain chips that can self-implant post-injection, ...

A neural interface framework integrating L2 regularization with attention supervision paradigms achieves 96.87% classification accuracy in EEG ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

Brain-computer interface technology has long belonged to the realm of science fiction, but it’s quickly emerging as a real-world innovation with the potential to transform how we live, work and ...

Neurosurgeon and Engineer Dr. Ben Rapoport, co-founder of Precision Neuroscience, joins WIRED to answer the internet's burning questions about the emerging technology of brain implants and ...